Literature DB >> 29034803

LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells.

Wanjun Yu1,2, Weidong Peng2, Hao Jiang2, Hanyun Sha3, Jipeng Li1.   

Abstract

Long non-coding RNAs have been implicated in human cancer but their mechanisms of action are mainly undocumented. In this study, we found that HOXA11-AS expression was upregulated in non-small cell lung cancer tissues and cell lines. High levels of HOXA11-AS expression were correlated with larger tumor size and lymph node metastasis. Functional analysis revealed that HOXA11-AS promotes non-small cell lung cancer cell proliferation and invasion. In particular, HOXA11-AS functions as a competing endogenous RNA to regulate transcriptional factor Sp1 expression via sponging miR-124. Collectively, our findings reveal an oncogenic role for HOXA11-AS in non-small cell lung cancer tumorigenesis.

Entities:  

Keywords:  HOXA11-AS; Sp1; miR-124; non–small cell lung cancer; tumorigenesis

Mesh:

Substances:

Year:  2017        PMID: 29034803     DOI: 10.1177/1010428317721440

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  Long non-coding RNA HOXA11-AS accelerates the progression of keloid formation via miR-124-3p/TGFβR1 axis.

Authors:  Jun Jin; Zhen-Hua Jia; Xiao-Hua Luo; Hong-Feng Zhai
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

2.  Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.

Authors:  Huiying Xu; Lingyan Wang; Xiuli Jiang
Journal:  Mol Cell Biochem       Date:  2020-11-10       Impact factor: 3.396

3.  HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2.

Authors:  Wen-Long Zhang; Ya-Nan Zhao; Zhang-Zhen Shi; Gui-Ying Gu; Dan Cong; Chen Wei; Yuan-Song Bai
Journal:  Hum Cell       Date:  2019-09-06       Impact factor: 4.174

4.  LncRNA HOXA11-AS accumulation-induced microRNA-761 downregulation regulates cell growth by targeting TRIM29 in papillary thyroid cancer.

Authors:  Xiangdang Yin; Jian Zhang; Chaojun Li; Zhe Zhang; Tong Jin; Liyou Song; Rui Zhang; Wei Wang; Youmao Tao; Xiaochun Wang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

5.  LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.

Authors:  Rogayeh Soltani; Mohammad Amini; Marziyeh Mazaheri Moghaddam; Asiyeh Jebelli; Sahar Ahmadiyan; Negar Bidar; Behzad Baradaran; Habib MotieGhader; Milad Asadi; Ahad Mokhtarzadeh
Journal:  Mol Biol Rep       Date:  2022-01-04       Impact factor: 2.742

Review 6.  Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer.

Authors:  Min Su; Yuhang Xiao; Jinming Tang; Jie Wu; Junliang Ma; Bo Tian; Yong Zhou; Hui Wang; Desong Yang; Qian-Jin Liao; Wenxiang Wang
Journal:  J Cancer       Date:  2018-10-18       Impact factor: 4.207

7.  HOXA11-AS promotes the progression of oral squamous cell carcinoma by targeting the miR-518a-3p/PDK1 axis.

Authors:  Baojun Li; Wei Wang; Susheng Miao; Guofu Li; Yuanjing Lv; Cheng Xiang; Rong Pei
Journal:  Cancer Cell Int       Date:  2019-05-21       Impact factor: 5.722

8.  miR-124-3p targeted SIRT1 to regulate cell apoptosis, inflammatory response, and oxidative stress in acute myocardial infarction in rats via modulation of the FGF21/CREB/PGC1α pathway.

Authors:  Yun-Jie Wei; Jun-Feng Wang; Fei Cheng; Hai-Jun Xu; Jia-Juan Chen; Jian Xiong; Jing Wang
Journal:  J Physiol Biochem       Date:  2021-06-19       Impact factor: 4.158

Review 9.  HOXA11-AS: a novel regulator in human cancer proliferation and metastasis.

Authors:  Jiang-Yang Xue; Chao Huang; Wei Wang; Hai-Bo Li; Ming Sun; Min Xie
Journal:  Onco Targets Ther       Date:  2018-07-27       Impact factor: 4.147

10.  A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.

Authors:  Alberto Cedro-Tanda; Magdalena Ríos-Romero; Sandra Romero-Córdoba; Mireya Cisneros-Villanueva; Rosa Gloria Rebollar-Vega; Luis Alberto Alfaro-Ruiz; Silvia Jiménez-Morales; Carlos Domínguez-Reyes; Felipe Villegas-Carlos; Alberto Tenorio-Torres; Veronica Bautista-Piña; Fredy Omar Beltrán-Anaya; Alfredo Hidalgo-Miranda
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.